Literature DB >> 1649557

Tumor necrosis factor receptors in lymphoid tissues and lymphomas. Source and site of action of tumor necrosis factor alpha.

B Ryffel1, M Brockhaus, U Dürmüller, F Gudat.   

Abstract

Tumor necrosis factor alpha (TNF alpha), which is produced by germinal center dendritic reticulum cells (DRC) in lymphoid tissue, plays a regulatory role in a local immune response. However no information is available on the nature and location of cells responding to this cytokine. Thus TNF receptor distribution was investigated in situ by immunohistochemistry using monoclonal antibodies directed against the p75 and p55 receptor proteins. Receptor expression was unique and restricted to the lymphoreticular tissue. The p75 receptor was found on activated lymphocytes and interdigitating reticulum cells of the T-cell area, whereas the p55 receptor was confined to the germinal center DRCs, which are the main site of TNF alpha production. The two receptor proteins were expressed on distinct cell populations of the lymphoid system and no coexpression was observed. Preliminary results indicate that TNF receptor (TNFR) expression is regulated; Upregulation of TNFR proteins was found in reactive hyperplasia together with increased TNF alpha expression. In lymphoproliferative disorders, expression of the p75 receptor and TNF alpha was found mainly in high-grade malignant non-Hodgkin lymphomas. In summary, TNF alpha produced by germinal center DRCs might regulate an in vivo immune response through autocrine and paracrine pathways. Thus TNF alpha might signal, through the distinct TNFR proteins, the p55 and p75 receptor, which are expressed on different cell types in lymphoid tissue.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649557      PMCID: PMC1886126     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  Expression of tumor necrosis factor receptors on human monocytes and internalization of receptor bound ligand.

Authors:  K Imamura; D Spriggs; D Kufe
Journal:  J Immunol       Date:  1987-11-01       Impact factor: 5.422

2.  Quantification and characterization of high-affinity membrane receptors for tumor necrosis factor on human leukemic cell lines.

Authors:  P Scheurich; U Ucer; M Krönke; K Pfizenmaier
Journal:  Int J Cancer       Date:  1986-07-15       Impact factor: 7.396

3.  Human lymphotoxin obtained from established lymphoid lines: purification characteristics and inhibition by anti-immunoglobulin.

Authors:  N Amino; E S Linn; T J Pysher; R Mier; G E Moore; L J DeGroot
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

Review 4.  Lymphotoxin.

Authors:  N L Paul; N H Ruddle
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

5.  In vivo immunohistochemical identification of tumor necrosis factor/cachectin in human lymphoid tissue.

Authors:  J L McCall; K Yun; S Funamoto; B R Parry
Journal:  Am J Pathol       Date:  1989-09       Impact factor: 4.307

6.  Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses.

Authors:  P Scheurich; B Thoma; U Ucer; K Pfizenmaier
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

7.  Specificity of tumor necrosis factor toxicity for human mammary carcinomas relative to normal mammary epithelium and correlation with response to doxorubicin.

Authors:  C Dollbaum; A A Creasey; S H Dairkee; A J Hiller; A R Rudolph; L Lin; C Vitt; H S Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

8.  Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences.

Authors:  Z Dembic; H Loetscher; U Gubler; Y C Pan; H W Lahm; R Gentz; M Brockhaus; W Lesslauer
Journal:  Cytokine       Date:  1990-07       Impact factor: 3.861

9.  Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody.

Authors:  S S Sung; J M Bjorndahl; C Y Wang; H T Kao; S M Fu
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

10.  Effect of tumor necrosis factor alpha on mitogen-activated human B cells.

Authors:  J H Kehrl; A Miller; A S Fauci
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Peyer's patch organogenesis--cytokines rule, OK?

Authors:  G Mayrhofer
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

2.  A murine xenograft model for human CD30+ anaplastic large cell lymphoma. Successful growth inhibition with an anti-CD30 antibody (HeFi-1).

Authors:  W Pfeifer; E Levi; T Petrogiannis-Haliotis; L Lehmann; Z Wang; M E Kadin
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

3.  Relationship between soluble tumor necrosis factor (TNF) receptors and TNF alpha during immunotherapy with interleukin-2 and/or interferon alpha.

Authors:  R Landmann; U Keilholz; C Scheibenbogen; M Brockhaus; H Gallati; H Denz; M Bargetzi; C Ludwig
Journal:  Cancer Immunol Immunother       Date:  1994-02       Impact factor: 6.968

Review 4.  The role of T cells in the microenvironment of Hodgkin lymphoma.

Authors:  Frederik Wein; Ralf Küppers
Journal:  J Leukoc Biol       Date:  2015-08-28       Impact factor: 4.962

5.  The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiation.

Authors:  U Trefzer; M Brockhaus; H Lötscher; F Parlow; A Budnik; M Grewe; H Christoph; A Kapp; E Schöpf; T A Luger
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

6.  Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells.

Authors:  H Spiegel; H Herbst; G Niedobitek; H D Foss; H Stein
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

7.  IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma.

Authors:  Katherine R Calvo; Bhavana Dabir; Alexandra Kovach; Christopher Devor; Russell Bandle; Amelia Bond; Joanna H Shih; Elaine S Jaffe
Journal:  Blood       Date:  2008-08-05       Impact factor: 22.113

8.  Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia.

Authors:  G A Spinas; U Keller; M Brockhaus
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

9.  Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.

Authors:  M S Naylor; G W Stamp; W D Foulkes; D Eccles; F R Balkwill
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

10.  Pretreatment Liver Injury Predicts Poor Prognosis of DLBCL Patients.

Authors:  Qing Shi; Rong Shen; Chao-Fu Wang; Xing Fan; Ying Qian; Bin-Shen Ou-Yang; Yan Zhao; Christophe Leboeuf; Anne Janin; Shu Cheng; Li Wang; Wei-Li Zhao
Journal:  Mediators Inflamm       Date:  2017-09-17       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.